Antiviral Activity of <i>trans</i> -Hexenoic Acid against Coxsackievirus B and Enterovirus A71-Reference-Cited by-同舟云学术

Antiviral Activity of trans -Hexenoic Acid against Coxsackievirus B and Enterovirus A71

Published:2023-02-14 Issue: Volume: Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Olasunkanmi Oluwatayo Israel¹,Fei Yanru¹,Avala Ntsigouaye Juval¹,Yi Ming¹,Wang Yao²,Liu Jinchang¹,Cheng Weixu¹,Megeto James¹,Bashir Tahira²,Chen Yang¹,Xu Weizhen¹,Lin Lexun¹,Zhao Wenran²^ORCID,Wang Yan¹^ORCID,Zhong Zhaohua¹^ORCID

Affiliation:

1. Department of Microbiology, Harbin Medical University, Harbin, China

2. Department of Cell Biology, Harbin Medical University, Harbin, China

Abstract

Enterovirus infections are life-threatening viral infections which occur mainly among children and are possible causes of viral outbreak. Until now, treatment and management of infections caused by members of the genus Enterovirus largely depended on supportive care, and no antiviral medications are currently approved for the treatment of most of these infections.

Funder

National Natural Science Foundation of China

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.00868-22

Reference36 articles.

1. Picornaviruses

2. Type B coxsackieviruses and their interactions with the innate and adaptive immune systems

3. Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis

4. N-Acetyl cysteine effectively alleviates Coxsackievirus B-Induced myocarditis through suppressing viral replication and inflammatory response

5. Eradication of persistent coxsackievirus B infection from a pancreatic cell line with clinically used antiviral drugs